Pfizer says Canada has selected its “Abrysvo” RSV vaccine for use in adults 60 and over for the upcoming virus season. “Abrysvo” is also approved for use in pregnant people to provide protection to infants. Katherine Ward has this story and more in Health Matters for Sept. 19, 2024.
Health Matters
Health Matters: Canada to use Pfizer’s ‘Abrysvo’ RSV vaccine
More Videos
-
Health Matters: Dozens sickened after eating BC oysters
-
Health Matters: Nestle launches protein shots in U.S.
-
Health Matters: Canada Post workers seek improved health and safety measures on the job
-
Health Matters: LGBTQ2 advocates try to halt Alberta’s transgender bill
-
Cancer costs a patient $33K, Canadian Cancer Society report says
-
Health Matters: Alberta signs onto federal deal for rare disease drugs
You are viewing an Accelerated Mobile Webpage.
View Original Article